Our team is frequently featured in national journals and news networks —check out the articles below to learn more: Neurons Can Transfer Mitochondria to Cancer CellsJul 24, 2025Lab In The news Michael Bolton Brain Cancer: What Is Glioblastoma, What Are the Symptoms and Can You Prevent It?May 8, 2025Lab In The news Clinical Trials Are Moving Out of the Lab and Into People’s HomesMay 8, 2025Uncategorized Lab In The news New study highlights telehealth struggles in cancer careMay 8, 2025Lab In The news Injection Immunotherapies Get FDA ApprovalMay 8, 2025Lab In The news Integrated Proteogenomic Characterization of Glioblastoma Evolution: Overcoming Barriers to Develop Personalized Treatment StrategiesMay 8, 2025Uncategorized Lab In The news Signal Alert: Startup Seeks Community Funders for AAV Immuno-Gene TherapyMay 8, 2025Lab In The news Michael Bolton diagnosed with brain cancer glioblastoma. What is that?May 8, 2025Lab In The news The Khasraw Lab in Duke Health News Mustafa Khasraw to Lead U.S. Arm of International Glioblastoma TrialMay 12, 2025Uncategorized DUKE HEALTH Analysis Details Lasting Effects of the Covid-19 Pandemic on Cancer CareMay 12, 2025DUKE HEALTH Evaluation of fluoxetine (Prozac) and Cytotoxic Lysosomal Stress in Glioma (FLIrT)May 12, 2025DUKE HEALTH Q&A: The MOAB Trial – Now Enrolling. Click to learn more!May 12, 2025Uncategorized DUKE HEALTH PuMP: Oncolytic HSV1 MVR-C5252 in Patients with rHGG (Recurrent Glioma)May 12, 2025DUKE HEALTH Q&A: PuMP Trial for Recurrent GlioblastomaMay 12, 2025DUKE HEALTH
